Abstract
Introduction
Biomedical scientist (BMS) participation in examination and dissection (cut-up) of surgical pathology specimens has a long history in the UK, Europe and particularly in the USA where the role of the advanced, non-medical, "pathologist assistant" is well developed [1, 2] . Medical pathologist support for BMS cut up in the UK has had a chequered history stimulating fierce debate in the literature in the mid-nineteen nineties [3, 4, 5] , and still with a tendency to polarise pathologist opinion, especially around BMS input into the more complex specimens.
In 2001 the Royal college of Pathologists (RCPath) issued draft guidelines for the involvement of BMS in cut-up [6] that included an appendix outlining the different categories of specimen complexity from A to D. The 2001 draft guidance was superseded by a final report published by a joint working party of the RCPath and Institute of Biomedical Science (IBMS) in January 2004 [7] that outlined an initial review of the experience of UK sites piloting the extended role of the BMS, and discussing benefits, problems, constraints and funding. Benefits cited included;
• Release of consultant time for other professional activities
• Increased job satisfaction and career opportunities for BMS
• Development of team-work within the laboratory
• More flexible and efficient use of cut up facilities 4 Importantly there was no perceived detrimental effect on the overall standard of histopathological reporting, timeliness, or professional practice providing principles of good practice are adhered to standard operating procedures (SOPs), training and audit measures are in place.
Following the report many departments have renewed efforts to develop BMS cut-up to some degree with benefits reported including release of consultant time and stricter adherence to trimming SOPs, outweighing the slight increase of blocks and slide levels generated, and with no reduction in quality of dissection. [8, 9] . In 2004 we successfully secured funding to • BMS photographs the specimen and commences cut up according to the SOP.
• Consultant available to review specimen again at any time during cut up.
• Discussion of block selection and further feedback undertaken on all cases at the double-headed microscope. When a relatively low lymph node harvest was achieved on first dissection (<10 nodes), the BMS was encouraged to undertake a second search on a case-by-case basis following further discussion with the consultant pathologist.
2) BMS microscopic pre-reporting of cases
On every study case core macroscopic data items were discussed between the supervising consultant and the BMS. The microscopic features were also discussed in all cases using a double-headed • Dukes' stage; Dukes A 8/50 (16%), Dukes B 18/50 (36%), Dukes C1 20/50 (40%), Dukes C2 4/50 (8%)
• Mean lymph node harvest; 13.78
• Serosal involvement; 12/50 (24%)
• Vascular invasion; 21/50 (42%)
• Mean number of tumour blocks taken; 5.6 35%, Duke's C 50%) [12] . The BMS achieved all performance targets with a slightly higher extramural vascular invasion rate for the BMS of 42% (target 25%) against 37% for the pathologists. The BMS generated slightly more tumour blocks than pathologists (BMS mean 5.6, pathologists mean 5.0). A slightly lower mean lymph node harvest of 13.78 (target 12) was achieved by the BMS against 15.73, and a lower serosal involvement figure of 24% (target 20%) against 41% for the pathologists. Case bias towards less complex cases may have had a small negative impact on those parameters. In a recent review on reporting colorectal cancer the suggestion is that all departments should aspire to the published lymph node harvest mean from the best centres of 15-18 nodes, and find extramural vascular invasion in 30% of colon cancers [13] . A second search for nodes in our cases with an initial low yield did increase lymph node numbers, although precise records were not kept to expand on that observation. There is published evidence for a positive effect on nodal yield from second dissection, but little evidence of any influence on staging and hence patient management [14] .
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The saving in consultant time resulting from BMS cut up once supervision time is taken into account was 17. 
